‘Sitagliptin,’ DPP- inhibitors acquire exclusive sale rights

Published: 2016-01-27 13:34:59

Updated: 2016-01-27 13:34:59

Some of drugs having ‘sitagliptin,’ an antidiabetic substance, acquired the exclusive sale right.

On the 22^nd, the Ministry of Food and Drug Safety granted 3 products of ‘sitagliptin phosphate hydrate+metformin hydrochloride,’ a product of ‘sitagliptin phosphate hydrate’ and a product of ‘sitagliptin phosphate’ for the 14^th to 18^th exclusive sale rights.

Sitagliptin is a main substance of ‘Ja...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.